Thomas Vogl takes up tenure-track assistant professorship at MedUni Vienna

Assistant Professorship in "Microbiome in Cancer Immunology" under the tenure-track model at the Medical University of Vienna. Focusing on interdisciplinary research in immunology, oncology, and microbiology, he has been leading a research group at the Center for Cancer Research at the Medical University of Vienna since August 2022. In recent years it has been increasingly appreciated that certain cancer therapies are beneficially affected by a diverse, healthy composition of intestinal microbes. The gut microbiome refers to this collective of bacteria living in our intestines. These strains can play a significant role in activating the immune system to fight cancer cells. At the same time, however, other bacterial strains have been linked to the occurrence of certain cancers, such as colorectal cancer. How the immune system differentiates between beneficial and harmful microbes, and how these individually influence cancers, is only incompletely understood.